AI-Driven Literature Curation for Determining Genomic Variant Pathogenicity
Mark Kiel, Founder and Chief Science Officer of Genomenon was a featured presenter for the LabRoots Virtual Genetics & Genomics Event on May 8th and 9th, 2019. This is the transcript, slides and video from his talk, which opened the event on Thursday, May 9th.
Genomenon Honored as one of 50 Companies to Watch 2019
Mike Klein, CEO of Genomenon, as interviewed by Jeffrey Mosher, Operations Director of Michigan Business Network on Genomenon’s recent award as one of the Top 50 Companies to Watch in Michigan.
Don’t Call It a Comeback
Mark Kiel, Founder and Chief Science Officer of Genomenon, shares his comeback story at Startup Story Night 2019 at the Marble Bar in Detroit. Genomenon has come a very long way. Like any good story, we had our ups and downs, moments of excitement and fear while rapidly growing in a developing industry. Read about …
The Entirety of Genomic Literature, Now in Moon with Mastermind
A guest post from Peter Schols, CEO of Diploid: This week, our team at Diploid announced exciting news: We have integrated the Mastermind Genomic Search Engine into Moon to accelerate the diagnostic process for rare disease.
5 Key Considerations when Selecting a Variant Database
With millions of human genetic variants cited in over 30 million articles, comprehensively searching the medical research for a variant can be like finding a needle in a haystack. This is especially important when a single paper can mean the difference between a variant of uncertain significance (VUS) and a pathogenic variant.